33. Rosenberg SA, Aebersold P, Cornetta K, et al. Gene transfer 
into humans-immunotherapy of patients with advanced 
melanoma, using tumor-infiftrating lymphocytes modified by 
retroviral gene transduction. New Engl J Med 323:570-578 
(1990). 
34. Anderson WF. Steady Progress [Editorial]. Human Gene Ther 
2:99-100 (1991). 
35. Jolly DJ. HIV infection and gene transfer therapy. Human Gene 
Ther 2:111-112 (1991). 
36. Barber JD, Jolly DJ, St. Louis D, et al. Utilization of retroviral 
vectors for the potential treatment of AIDS. Annual Review of 
AIDS Research 1991 (in press). 
37. Donahue RE, Kessler SW, Bodine D, et al. Helper virus induced 
T-cell lymphoma in non-human primates following retroviral 
mediated gene transfer. J. Exp. Med. (in press). 
38. Kasid A, Morecki S, Abersold P, et al. Human gene transfer: 
Characterization of human tumor infiltrating lymphocytes as 
vehicles for retroviral-mediated gene transfer in man. PNAS 
87:473-77, 1990. 
39. Abrahamsen TG, Carter CS, Rubin M, et al. Large scale 
separation of peripheral blood monocytes: Influence of 
elutriation medium and storage conditions on inflammatory 
mediator release. J Clin Apheresis 6: 48-53, 1991. 
40. Carter CS, Leitman SF, Cullis H, et al. Technical aspects of 
lymphokine-activated killer production. J Clin Apheresis 4:113- 
117,1988. 
41. Aebersold P, Carter CS, Hyatt C, et al. A simplified automated 
procedure for generation of lymphokine-activated killer cells for 
use in clinical trials. J Immunol Methods 1 12:1-7, 1988. 
42. Muul LM, Nason-Burchenal K, Carter CS, et al. Development of 
an automated dosed system for generation of human 
lymphokine-activated killer (LAK) cells for use in adoptive 
immunotherapy. J Immunol Methods 101:171-181,1987. 
[314] 
Recombinant DNA Research, Volume 16 
